Expert Review of Vaccines

Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
pp. 293-295(3)
Authors: Pulickal, Anoop S; Pollard, Andrew J

Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting
pp. 297-300(4)
Author: Beall, Bernard

Artificial antigens for HIV vaccine design
pp. 301-303(3)

Nasal influenza vaccine enters Phase I clinical trial
pp. 305-305(1)

BiovaxID™ idiotype vaccination: active immunotherapy for follicular lymphoma
pp. 307-317(11)
Author: Flowers, Christopher R

HIV-1 rational vaccine design: molecular details of b12-gp120 complex structure
pp. 319-321(3)
Authors: Phogat, Sanjay K; Kaminsky, Stephen M; Koff, Wayne C

Oral vaccination against bovine tuberculosis with Mycobacterium bovis BCG
pp. 323-331(9)
Authors: Cross, Martin L; Aldwell, Frank

Optimizing dendritic cell-based immunotherapy for cancer
pp. 333-345(13)
Authors: Zhong, Hua; Shurin, Michael R; Han, Baohui

T-cell immunity generated by recombinant adenovirus vaccines
pp. 347-356(10)
Authors: Yang, Teng Chih; Millar, James B; Grinshtein, Natalie; Bassett, Jennifer; Finn, Jonathan; Bramson, Jonathan L

Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design
pp. 357-368(12)
Authors: Sant, Andrea J; Chaves, Francisco A; Krafcik, Frederick R; Lazarski, Christopher A; Menges, Paula; Richards, Katherine; Weaver, Jason M

Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design
pp. 357-368(12)
Authors: Sant, Andrea J; Chaves, Francisco A; Krafcik, Frederick R; Lazarski, Christopher A; Menges, Paula; Richards, Katherine; Weaver, Jason M

Cell-mediated immune responses induced by BHV-1: rational vaccine design
pp. 369-380(12)
Author: van Drunen Littel-van den Hurk, Sylvia

Virus-like particles: flexible platforms for vaccine development
pp. 381-390(10)
Author: Chackerian, Bryce

Smart adjuvants
pp. 391-400(10)
Authors: Schmidt, Clint S; Morrow, W John W; Sheikh, Nadeem A

Implication of nanoparticles/microparticles in mucosal vaccine delivery
pp. 401-418(18)
Authors: Vyas, Suresh P; Gupta, Prem N

Intranasal vaccines for protection against resipratory and systemic bacterial infections
pp. 419-429(11)
Authors: Oliveira, Maria Leonor Sarno; Arêas, Ana Paula Mattos; Ho, Paulo Lee

Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
pp. 431-440(10)
Author: Lewis, George K

Next generation: tuberculosis vaccines that elicit protective CD8⁺ T cells
pp. 441-456(16)
Authors: Behar, Samuel M; Woodworth, Joshua SM; Wu, Ying

Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines
pp. 457-465(9)
Authors: Avakian, Alan P; Poston, Rebecca M; Kong, Fan-kun; Van Kampen, Kent R; Tang, De-chu C